About this episode
Resources for the Community: ___________________________________________________________________ Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55 Ro GLP-1 Insurance Checker https://ro.co/weight-loss/glp1-insurance-checker/ Ro GLP-1 Supply and Shortage Tracker https://ro.co/weight-loss/supply-tracker/ Learn more about Obesity https://www.obesityaction.org/ _____________________________________________________________________ Part 1 Priscilla bravely shares her community story. We chat with a cardiologist, Dr. Simin Lee, and discover the many benefits GLP1 medications have on our cardiovascular health. We cover the recent studies of semaglutide and the cardiovascular health improvements during clinical trials, and drill down to specific signs of what GLP1 medications could possibly improve. We discuss the responsive nature of GLP1 medications as it relates to gender, menopause and caring for the heart. We also talk about the new triple agonist coming down the pike, Retatrutide. _________________________________________________________________________ ⭐️Mounjaro Stanley⭐️ griffintumblerco.Etsy.com Use code PODCAST10 for $ OFF _________________________________________________________________________ Join this channel to get access to perks: / @theplussidez _________________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==